Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Walmrath

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
The Journal of Experimental Medicine|October 1, 1994
Endotoxin "priming" potentiates lung vascular abnormalities in response to Escherichia coli hemolysin: an example of synergism between endo- and exotoxinD Walmrath, H A Ghofrani, S Rosseau, et al.
Der Internist|July 28, 2017
[Disseminated osteolytic lesions in a 28-year-old refugee]T Karrasch, H D Walmrath, M Kampschulte, et al.
The European Respiratory Journal|May 28, 2002
Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on gas exchange and haemodynamicsD Walmrath, F Grimminger, D Pappert, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 10, 2001
Conebulization of surfactant and urokinase restores gas exchange in perfused lungs with alveolar fibrin formationR T Schermuly, A Günther, M Ermert, et al.
American Journal of Respiratory and Critical Care Medicine|January 1, 1996
Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edemaA Günther, C Siebert, R Schmidt, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 20, 2000
Subthreshold doses of specific phosphodiesterase type 3 and 4 inhibitors enhance the pulmonary vasodilatory response to nebulized prostacyclin with improvement in gas exchangeR T Schermuly, A Roehl, N Weissmann, et al.
European Journal of Clinical Investigation|November 1, 1993
Influence of intravenous n-3 lipid supplementation on fatty acid profiles and lipid mediator generation in a patient with severe ulcerative colitisF Grimminger, D Führer, C Papavassilis, et al.
Microvascular Research|July 1, 1995
Hydrogen peroxide-induced increase in lung endothelial and epithelial permeability--effect of adenylate cyclase stimulation and phosphodiesterase inhibitionW Seeger, T Hansen, R Rössig, et al.
The American Review of Respiratory Disease|April 1, 1991
Lung vascular injury after administration of viable hemolysin-forming Escherichia coli in isolated rabbit lungsW Seeger, R Obernitz, M Thomas, et al.
American Journal of Respiratory and Critical Care Medicine|February 15, 2000
Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndromeA Günther, P Mosavi, S Heinemann, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
The Journal of Experimental Medicine|October 1, 1994
Endotoxin "priming" potentiates lung vascular abnormalities in response to Escherichia coli hemolysin: an example of synergism between endo- and exotoxinD Walmrath, H A Ghofrani, S Rosseau, et al.
Der Internist|July 28, 2017
[Disseminated osteolytic lesions in a 28-year-old refugee]T Karrasch, H D Walmrath, M Kampschulte, et al.
The European Respiratory Journal|May 28, 2002
Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on gas exchange and haemodynamicsD Walmrath, F Grimminger, D Pappert, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 10, 2001
Conebulization of surfactant and urokinase restores gas exchange in perfused lungs with alveolar fibrin formationR T Schermuly, A Günther, M Ermert, et al.
American Journal of Respiratory and Critical Care Medicine|January 1, 1996
Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edemaA Günther, C Siebert, R Schmidt, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 20, 2000
Subthreshold doses of specific phosphodiesterase type 3 and 4 inhibitors enhance the pulmonary vasodilatory response to nebulized prostacyclin with improvement in gas exchangeR T Schermuly, A Roehl, N Weissmann, et al.
European Journal of Clinical Investigation|November 1, 1993
Influence of intravenous n-3 lipid supplementation on fatty acid profiles and lipid mediator generation in a patient with severe ulcerative colitisF Grimminger, D Führer, C Papavassilis, et al.
Microvascular Research|July 1, 1995
Hydrogen peroxide-induced increase in lung endothelial and epithelial permeability--effect of adenylate cyclase stimulation and phosphodiesterase inhibitionW Seeger, T Hansen, R Rössig, et al.
The American Review of Respiratory Disease|April 1, 1991
Lung vascular injury after administration of viable hemolysin-forming Escherichia coli in isolated rabbit lungsW Seeger, R Obernitz, M Thomas, et al.
American Journal of Respiratory and Critical Care Medicine|February 15, 2000
Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndromeA Günther, P Mosavi, S Heinemann, et al.
Pageof 9